Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 1322

1.

Access of protective antiviral antibody to neuronal tissues requires CD4 T-cell help.

Iijima N, Iwasaki A.

Nature. 2016 May 18;533(7604):552-6. doi: 10.1038/nature17979.

PMID:
27225131
2.

Incidence of Co-Infections of HIV, Herpes Simplex Virus Type 2 and Syphilis in a Large Cohort of Men Who Have Sex with Men in Beijing, China.

Li D, Yang X, Zhang Z, Wang Z, Qi X, Ruan Y, Zhou Y, Li C, Luo F, Lau JT.

PLoS One. 2016 Jan 28;11(1):e0147422. doi: 10.1371/journal.pone.0147422. eCollection 2016.

3.

Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosa.

Oh JE, Kim BC, Chang DH, Kwon M, Lee SY, Kang D, Kim JY, Hwang I, Yu JW, Nakae S, Lee HK.

Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):E762-71. doi: 10.1073/pnas.1518589113. Epub 2016 Jan 25.

4.

The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.

Roura E, Travier N, Waterboer T, de Sanjosé S, Bosch FX, Pawlita M, Pala V, Weiderpass E, Margall N, Dillner J, Gram IT, Tjønneland A, Munk C, Palli D, Khaw KT, Overvad K, Clavel-Chapelon F, Mesrine S, Fournier A, Fortner RT, Ose J, Steffen A, Trichopoulou A, Lagiou P, Orfanos P, Masala G, Tumino R, Sacerdote C, Polidoro S, Mattiello A, Lund E, Peeters PH, Bueno-de-Mesquita HB, Quirós JR, Sánchez MJ, Navarro C, Barricarte A, Larrañaga N, Ekström J, Lindquist D, Idahl A, Travis RC, Merritt MA, Gunter MJ, Rinaldi S, Tommasino M, Franceschi S, Riboli E, Castellsagué X.

PLoS One. 2016 Jan 25;11(1):e0147029. doi: 10.1371/journal.pone.0147029. eCollection 2016. Erratum in: PLoS One. 2016;11(3):e0151427.

5.

Sustained high prevalence of viral hepatitis and sexually transmissible infections among female sex workers in China: a systematic review and meta-analysis.

Su S, Chow EP, Muessig KE, Yuan L, Tucker JD, Zhang X, Ren J, Fairley CK, Jing J, Zhang L.

BMC Infect Dis. 2016 Jan 5;16:2. doi: 10.1186/s12879-015-1322-0. Review.

6.

Chlamydial Pre-Infection Protects from Subsequent Herpes Simplex Virus-2 Challenge in a Murine Vaginal Super-Infection Model.

Slade J, Hall JV, Kintner J, Schoborg RV.

PLoS One. 2016 Jan 4;11(1):e0146186. doi: 10.1371/journal.pone.0146186. eCollection 2016.

8.

[Efficacy of polyprenyl phosphates in the experimental genital herpes model].

Narovlyansky AN, Ivanova AM, Shevlyagina NV, Didenko LV, Borovaya TG, Izmest'eva AV, Sanin AV, Pronin AV, Ershov FI.

Vopr Virusol. 2015;60(4):9-13. Russian.

PMID:
26665428
9.

Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.

Blevins TP, Mitchell MC, Korom M, Wang H, Yu Y, Morrison LA, Belshe RB.

PLoS One. 2015 Dec 14;10(12):e0144738. doi: 10.1371/journal.pone.0144738. eCollection 2015.

10.
11.

High Rate of β-Globin DNA Detection Validates Self-Sampling in Herpes Simplex Virus Shedding Studies.

Mujugira A, Huang ML, Selke S, Drolette L, Magaret AS, Wald A.

Sex Transm Dis. 2015 Dec;42(12):705-9. doi: 10.1097/OLQ.0000000000000374.

PMID:
26562701
12.

Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding.

Johnston C, Corey L.

Clin Microbiol Rev. 2016 Jan;29(1):149-61. doi: 10.1128/CMR.00043-15. Review.

PMID:
26561565
13.

A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2.

Wang K, Goodman KN, Li DY, Raffeld M, Chavez M, Cohen JI.

J Virol. 2015 Nov 11;90(1):562-74. doi: 10.1128/JVI.01845-15.

14.

Tenofovir Gel to Prevent HSV-2 Infection.

Agut H, Burrel S, Boutolleau D.

N Engl J Med. 2015 Nov 12;373(20):1980. doi: 10.1056/NEJMc1511338#SA2. No abstract available.

PMID:
26559586
15.

Tenofovir Gel to Prevent HSV-2 Infection.

Feder HM Jr.

N Engl J Med. 2015 Nov 12;373(20):1980. doi: 10.1056/NEJMc1511338#SA1. No abstract available.

PMID:
26559585
16.

Tenofovir Gel to Prevent HSV-2 Infection.

Abdool Karim SS, Abdool Karim Q, Gengiah TN.

N Engl J Med. 2015 Nov 12;373(20):1980-1. doi: 10.1056/NEJMc1511338. No abstract available.

17.

Mixed primary infection by herpes simplex virus 1 and 2 in a 5-month-old infant with no evidence of sexual abuse.

Patwardhan V, Bhalla P, Sardana K, Sethi S.

Indian J Dermatol Venereol Leprol. 2015 Nov-Dec;81(6):612-4. doi: 10.4103/0378-6323.168340. No abstract available.

18.

Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012.

Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, Newman LM.

PLoS One. 2015 Oct 28;10(10):e0140765. doi: 10.1371/journal.pone.0140765. eCollection 2015.

19.

Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda.

Phipps W, Nakku-Joloba E, Krantz EM, Selke S, Huang ML, Kambugu F, Orem J, Casper C, Corey L, Wald A.

J Infect Dis. 2016 Feb 1;213(3):439-47. doi: 10.1093/infdis/jiv451. Epub 2015 Oct 20.

PMID:
26486633
20.

Genital infections and risk of premature rupture of membranes in Mulago Hospital, Uganda: a case control study.

Nakubulwa S, Kaye DK, Bwanga F, Tumwesigye NM, Mirembe FM.

BMC Res Notes. 2015 Oct 16;8:573. doi: 10.1186/s13104-015-1545-6.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk